Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-2
pubmed:abstractText
Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a high risk breast cancer that lacks the benefit of specific therapy that targets these proteins.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
(c) 2006 American Cancer Society.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
109
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25-32
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17146782-Adult, pubmed-meshheading:17146782-Aged, pubmed-meshheading:17146782-Breast Neoplasms, pubmed-meshheading:17146782-Cadherins, pubmed-meshheading:17146782-Carcinoma, Ductal, Breast, pubmed-meshheading:17146782-Female, pubmed-meshheading:17146782-Follow-Up Studies, pubmed-meshheading:17146782-Genes, erbB-2, pubmed-meshheading:17146782-Humans, pubmed-meshheading:17146782-Immunohistochemistry, pubmed-meshheading:17146782-Microarray Analysis, pubmed-meshheading:17146782-Middle Aged, pubmed-meshheading:17146782-Phenotype, pubmed-meshheading:17146782-Prognosis, pubmed-meshheading:17146782-Receptor, Epidermal Growth Factor, pubmed-meshheading:17146782-Receptors, Androgen, pubmed-meshheading:17146782-Receptors, Estrogen, pubmed-meshheading:17146782-Receptors, Progesterone, pubmed-meshheading:17146782-Tumor Markers, Biological
pubmed:year
2007
pubmed:articleTitle
Prognostic markers in triple-negative breast cancer.
pubmed:affiliation
Department of Histopathology, Molecular Medical Sciences, University of Nottingham, Nottingham, United Kingdom.
pubmed:publicationType
Journal Article